JP2000198714A - Antioxidant and composition containing the same - Google Patents

Antioxidant and composition containing the same

Info

Publication number
JP2000198714A
JP2000198714A JP11002510A JP251099A JP2000198714A JP 2000198714 A JP2000198714 A JP 2000198714A JP 11002510 A JP11002510 A JP 11002510A JP 251099 A JP251099 A JP 251099A JP 2000198714 A JP2000198714 A JP 2000198714A
Authority
JP
Japan
Prior art keywords
antioxidant
extract
lancifolia
bursera
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11002510A
Other languages
Japanese (ja)
Other versions
JP3597068B2 (en
Inventor
Satoshi Yoshitani
敏 吉谷
Fuminobu Yoshimi
文伸 吉見
Homare Tabata
誉 多葉田
Hiroyuki Haraguchi
博行 原口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Priority to JP251099A priority Critical patent/JP3597068B2/en
Publication of JP2000198714A publication Critical patent/JP2000198714A/en
Application granted granted Critical
Publication of JP3597068B2 publication Critical patent/JP3597068B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain an antioxidant having high anti-oxidizing power, controlling active oxygen and lipid peroxide formed in vivo, having excellent safety by making the antioxidant include an extract of Bursera lancifolia. SOLUTION: This antioxidant contains preferably 0.001-20.0 wt.%, calculated as dried substance based on the total of an extract, of Bursera lancifolia (gomosilla) (a plant of the genus Brucella of the family Burseraceae native to Mexico), preferably an extract from either of leaf or stem of Bursera lancifolia or a mixture of both of the leaf and the stem. Preferably, the amount of an extracting solvent such as water and a water-soluble solvent (e.g. ethanol) used is 100 pts.-wt. based on 5-50 pts.wt. of dried plant or green plant calculated as dried plant.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、抗酸化剤及び該抗
酸化剤を含有する組成物に関するものである。更に本発
明は、該抗酸化剤を含有する医薬品、医薬部外品、化粧
品などの分野に利用可能な皮膚外用剤に関するものであ
る。
TECHNICAL FIELD The present invention relates to an antioxidant and a composition containing the antioxidant. Furthermore, the present invention relates to an external preparation for skin that can be used in the fields of pharmaceuticals, quasi-drugs, cosmetics and the like containing the antioxidant.

【0002】[0002]

【従来の技術】近年、生体内で生成される活性酸素が、
不飽和脂肪酸と反応して過酸化脂質を生じ、人体に悪影
響を及ぼすことが明らかになってきている。例えば、活
性酸素は、虚血障害や放射線障害、過酸化脂質やその酸
化分解物は、核酸や蛋白に作用し、動脈硬化、高血圧
症、それらにより発症するによる血管障害、肝機能障
害、網膜症や白内障などを引き起こす。特に皮膚では、
紫外線などの環境因子の刺激を直接受けるため、活性酸
素が生成しやすく、活性酸素濃度の上昇、過酸化脂質の
生成等のシミ・ソバカス等の異常な色素沈着、炎症、浮
腫、壊死、皺、老化等その影響が顕著である。
2. Description of the Related Art In recent years, active oxygen generated in a living body has
It has become clear that it reacts with unsaturated fatty acids to produce lipid peroxide, which has a bad effect on the human body. For example, active oxygen ischemic injury and radiation injury, lipid peroxide and its oxidized degradation products act on nucleic acids and proteins, and cause arteriosclerosis, hypertension, vascular injury, hepatic dysfunction, and retinopathy caused by them. And cataracts. Especially on the skin,
Because it is directly stimulated by environmental factors such as ultraviolet rays, active oxygen is likely to be generated, increasing active oxygen concentration, abnormal pigmentation such as spots and freckles such as the production of lipid peroxide, inflammation, edema, necrosis, wrinkles, Aging and the effects are remarkable.

【0003】又、化粧品、医薬品、飲食品等において
は、油脂類を含有するものが多く、保存中や使用時に活
性酸素と反応して過酸化脂質を生成し、これによる品質
低下や栄養の低下・人体への毒性の発現が大きな問題に
なっている。
In addition, many cosmetics, pharmaceuticals, foods and beverages contain fats and oils, which react with active oxygen during storage or use to produce lipid peroxides, thereby reducing quality and reducing nutrition. -Expression of toxicity to the human body is a major problem.

【0004】このために、従来より生体内過酸化脂質異
常を改善するために、抗酸化作用を有する薬剤の探索研
究が、広く行われている。代表的なものでは、天然物抗
酸化剤として、脂溶性のトコフェロール(ビタミンE)
や、水溶性のアスコルビン酸(ビタミンC)があり、合
成抗酸化剤としてBHT(3,5-tert-butyl-4-hydroxyto
len)やBHA(2,(3)-tert-butyl-hydroxyanysol)等
が挙げられるが、その効果は満足できるものではなかっ
た。
[0004] For this reason, in order to improve the abnormalities of lipid peroxide in the living body, investigations for drugs having an antioxidant action have been widely conducted. As a typical example, fat-soluble tocopherol (vitamin E) is used as a natural product antioxidant.
And water-soluble ascorbic acid (vitamin C), and BHT (3,5-tert-butyl-4-hydroxyto) as a synthetic antioxidant.
len) and BHA (2, (3) -tert-butyl-hydroxyanysol) and the like, but their effects were not satisfactory.

【0005】これに対し、生体内過酸化脂質異常を改善
するために、抗酸化作用の高い物質を得ようという試み
が数多くなされており、種々の生薬抽出物が開示されて
いる(例えば、特開平5-246877号、特開平8-92053号、
特開平8-301745号等)。
On the other hand, many attempts have been made to obtain a substance having a high antioxidant activity in order to improve abnormalities of lipid peroxide in the living body, and various crude drug extracts have been disclosed (for example, Japanese Patent Application Laid-Open No. H11-157556). Kaihei 5-246877, JP-A-8-92053,
JP-A-8-301745).

【0006】[0006]

【発明が解決しようとする課題】しかし、上記生薬抽出
物は、トコフェロールやアスコルビン酸等に比べれば、
ある程度高い抗酸化作用を持つが、その作用は満足すべ
きものではない。又、合成抗酸化剤のBHT、BHAに
は、発癌性の疑いが持たれている等の問題がある。従っ
て、これらの抗酸化剤の他に同様の過酸化脂質生成の抑
制手段を有し、かつ安全性の高い物質が望まれている。
However, the above crude drug extract is more effective than tocopherol and ascorbic acid.
Although it has a somewhat high antioxidant effect, its effect is not satisfactory. Further, the synthetic antioxidants BHT and BHA have problems such as suspected carcinogenicity. Therefore, in addition to these antioxidants, a substance having similar means for suppressing lipid peroxide production and having high safety is desired.

【0007】[0007]

【課題を解決するための手段】本発明者らは、このよう
な状況を鑑み、従来技術の問題点を改良せんとして鋭意
研究を重ねた結果、驚くべきことにカンラン科の植物で
あるブルセラ・ランシフォリア(ゴモシーラ)[Bursera
lancifolia(GOMOSILLA)]の抽出物が、強いフリーラジ
カル消去作用、抗酸化作用を有することを見出した。
In view of such circumstances, the present inventors have conducted intensive studies to improve the problems of the prior art, and as a result, surprisingly, Brucella, a plant belonging to the orchid family. Ransifolia (gomosilla) [Bursera
lancifolia (GOMOSILLA)] extract has strong free radical scavenging and antioxidant effects.

【0008】すなわち、本発明は、カンラン科の植物で
あるブルセラ・ランシフォリア(ゴモシーラ)[Bursera
lancifolia(GOMOSILLA)]の抽出物を含有することを特
徴とする抗酸化剤及びこの抗酸化剤を含有する化粧品、
食品、医薬品等の組成物を提供するものである。
[0008] That is, the present invention relates to a plant of the family Orchidaceae, Brucella ransifolia (Gomosilla) [Bursera
lancifolia (GOMOSILLA)], and an antioxidant characterized by comprising an extract of
It is intended to provide a composition for a food, a medicine and the like.

【0009】[0009]

【発明の実施の形態】以下、本発明の実施の形態を詳述
する。発明に用いるブルセラ・ランシフォリア(Burser
a lancifolia)とは、メキシコ原産のカンラン科(Burs
eraceae)ブルセラ属に属する植物である。
Embodiments of the present invention will be described below in detail. Burser Lansifolia used in the invention (Burser
a lancifolia) is a type of Orchidaceae (Burs) native to Mexico.
eraceae) A plant belonging to the genus Brucella.

【0010】本発明で使用するブルセラ・ランシフォリ
ア(Bursera lancifolia)の抽出物とは、当該植物の
葉、茎、花、種子、果実、樹皮、根茎、根等の植物体の
一部または全部から抽出して得られるものである。好ま
しくは、葉もしくは茎の一方、又は両方の混合物から抽
出して得られるものがよい。又、一般的には乾燥あるい
は生植物をそのままあるいは裁断して使用する。使用す
る抽出溶媒は、当乾燥又は生植物の乾物換算当たり5〜
50部に対し下記抽出溶媒100部が用いられる。
[0010] The extract of Bursera lancifolia used in the present invention is extracted from a part or the whole of a plant such as a leaf, a stem, a flower, a seed, a fruit, a bark, a rhizome, a root, etc. of the plant. It is obtained by doing. Preferably, it is obtained by extracting from one of the leaves or the stem, or a mixture of both. In general, dried or raw plants are used as they are or cut. Extraction solvent to be used is 5 to 5 per dry matter or dry matter of raw plants.
For 50 parts, 100 parts of the following extraction solvent is used.

【0011】抽出溶媒としては、一般的には水、低級1
価アルコール類(メタノール、エタノール、1―プロパ
ノール、2―プロパノール、1―ブタノール、2―ブタ
ノール等)、液状多価アルコール(1,3―ブチレング
リコール、プロピレングリコール等)、低級アルキルエ
ステル(酢酸エチル等)、炭化水素(ベンゼン、ヘキサ
ン、ペンタン等)、ケトン類(アセトン、メチルエチル
ケトン等)、エーテル類(ジエチルエーテル、テトラヒ
ドロフラン、ジプロピルエーテル)、アセトニトリル等
が挙げられる。これらの溶媒は単独で用いても2種以上
を混合して用いても良い。好ましくは、水もしくは水溶
性溶媒(水との任意の割合で混合可能な溶媒。例えば、
エタノール、メタノール、プロピレングリコール等)の
うち1種又は2種以上の溶媒を用いるのがよい。
[0011] The extraction solvent is generally water, lower 1
Polyhydric alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene glycol, etc.), lower alkyl esters (ethyl acetate, etc.) ), Hydrocarbons (benzene, hexane, pentane, etc.), ketones (acetone, methyl ethyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, dipropyl ether), acetonitrile and the like. These solvents may be used alone or as a mixture of two or more. Preferably, water or a water-soluble solvent (a solvent that can be mixed with water at any ratio; for example,
It is preferable to use one or more solvents among ethanol, methanol, propylene glycol, etc.).

【0012】抽出方法は特に限定されないが、常温又は
加熱下で行われ、その方式としては通常抽出、ソックス
レー抽出等がある。抽出時間に制限はないが一般的には
1時間〜1週間が好ましい。
Although the extraction method is not particularly limited, the extraction is carried out at normal temperature or under heating, and examples of the method include ordinary extraction and Soxhlet extraction. The extraction time is not limited, but is generally preferably 1 hour to 1 week.

【0013】当該抽出液はそのまま使用しても良いが、
各種処理を施して使用することもできる。例えばこれら
を常圧あるいは減圧下で濃縮した濃縮液、又はさらに該
濃縮液中の溶媒を蒸発乾固させた固形物、また濃縮液か
ら晶析後濾別乾燥した固形物、又は濃縮液を凍結乾燥し
た固形物等が挙げられる。
The extract may be used as it is,
Various treatments can be performed before use. For example, a concentrated solution obtained by concentrating them under normal pressure or reduced pressure, or a solid obtained by evaporating the solvent in the concentrated solution to dryness, or a solid obtained by crystallizing from the concentrated solution and drying by filtration, or freezing the concentrated solution Dried solids and the like can be mentioned.

【0014】本発明に係るブルセラ・ランシフォリア
(Bursera lancifolia)の抽出物の抗酸化剤としての乾
物換算当たりの使用量(配合量)は、特に限定されない
が、総量を基準として0.001〜20.0重量%(以
下 wt%という)、特に0.01〜10wt%が望ま
しい。
The amount (blended amount) of the extract of Bursera lancifolia according to the present invention per dry matter equivalent as an antioxidant is not particularly limited, but is 0.001 to 20% based on the total amount. 0 wt% (hereinafter referred to as wt%), particularly 0.01 to 10 wt% is desirable.

【0015】本発明の抗酸化剤を含有する組成物は、上
記抗酸化剤を配合することを特徴とし、その用途は任意
であるが化粧品、食品、医薬品、医薬部外品、トイレタ
リー用品等に広く用いることができる。
The composition containing the antioxidant of the present invention is characterized by containing the above-mentioned antioxidant, and its use is optional, but it can be used in cosmetics, foods, pharmaceuticals, quasi-drugs, toiletries and the like. Can be widely used.

【0016】本発明が適用される化粧品としては、剤形
は特に限定されず、例えば、化粧水、乳液、クリーム、
ファンデーション、パック、口紅、洗顔料、シャンプ
ー、リンス、ヘアトニック等を挙げることができる。こ
れらの化粧品には、化粧品に一般的に用いられる各種成
分、すなわち水性成分、油性成分、粉末成分、アルコー
ル類、エステル類、界面活性剤、保湿剤、美白成分、紫
外線吸収剤、増粘剤、色剤、香料、抗酸化剤、pH調整
剤、キレート剤、防腐剤等の成分を配合することができ
る。
[0016] The cosmetics to which the present invention is applied are not particularly limited in dosage form, and include, for example, lotions, emulsions, creams,
Examples include foundations, packs, lipsticks, facial cleansers, shampoos, rinses, hair tonics, and the like. These cosmetics include various components generally used in cosmetics, that is, aqueous components, oily components, powder components, alcohols, esters, surfactants, humectants, whitening components, ultraviolet absorbers, thickeners, Components such as coloring agents, fragrances, antioxidants, pH adjusters, chelating agents, preservatives and the like can be added.

【0017】本発明が適用される食品は、特に限定され
ず、例えば一般食品として各々の食品原料に抽出物の所
要量を加え、通常の製造法により加工製造することによ
り得ることができる。
The food to which the present invention is applied is not particularly limited, and can be obtained, for example, by adding a required amount of an extract to each food raw material as a general food, and processing and producing the same by a usual production method.

【0018】本発明が適用される医薬品、医薬部外品と
しては、剤形は特に限定されず、例えば錠剤、顆粒剤、
カプセル剤、水薬等の内服剤、軟膏、パップ剤、クリー
ム、水剤などの外用剤、無菌溶液剤、懸濁液剤等の注射
剤、浴用剤等が挙げられる。これらの医薬品は、生理的
に認められるベヒクル、担体、賦形剤、結合剤、安定
剤、香味剤等と共に要求される単位用量形態をとりう
る。例えば、錠剤、カプセル剤のための組成物は、トラ
ガント、アラビアゴム、ゼラチン等の結合剤、微晶性セ
ルロース等の賦形剤、ゼラチン化澱粉、アルギン酸等の
膨化剤、ステアリン酸マグネシウム等の潤滑剤、ショ
糖、乳糖、サッカリンのような甘味剤、ペパーミント、
アカモノ油、チェリーのような香味剤等を共に混和し、
通常の方法によって処方することができる。また、注射
剤のための無菌組成物は、注射用水のようなベヒクル中
の活性物質、ゴマ油、ヤシ油、落花生油、綿実油のよう
な天然産出植物油、またはエチルオレートのような合成
脂肪ベヒクルを溶解又は懸濁させる通常の方法によって
処方することができる。外用剤としては基剤としてワセ
リン、パラフィン、油脂類、ラノリン、マクロゴール等
を用い、通常の方法によって軟膏剤、クリーム剤とす
る。
The pharmaceutical and quasi-drugs to which the present invention is applied are not particularly limited in dosage form, for example, tablets, granules,
Examples include internal preparations such as capsules and drenches, external preparations such as ointments, cataplasms, creams and liquid preparations, injections such as sterile solutions and suspensions, and bath preparations. These pharmaceuticals can take the required unit dosage forms with physiologically acceptable vehicles, carriers, excipients, binders, stabilizers, flavoring agents, and the like. For example, compositions for tablets and capsules include binders such as tragacanth, acacia, gelatin, excipients such as microcrystalline cellulose, gelatinized starch, leavening agents such as alginic acid, lubricating agents such as magnesium stearate. Agents, sucrose, lactose, sweeteners such as saccharin, peppermint,
Mix together red oil and flavoring agents like cherry,
It can be prescribed by a usual method. Sterile compositions for injections also dissolve the active substance in vehicles such as water for injection, naturally occurring vegetable oils such as sesame oil, coconut oil, peanut oil, cottonseed oil, or synthetic fat vehicles such as ethyl oleate. Alternatively, it can be formulated by a usual method of suspending. As an external preparation, vaseline, paraffin, oils and fats, lanolin, macrogol and the like are used as bases, and ointments and creams are prepared by a usual method.

【0019】本発明の皮膚外用剤とは、外用可能なあら
ゆる剤形を意味し、例えば、化粧水、乳液、クリーム、
ファンデーション、パック、エッセンス、口紅、洗顔
料、ゲル剤、エアゾル剤、軟膏、パップ剤、ペースト
剤、プラスター剤浴用剤、洗浄剤等の皮膚に適用される
ものや、シャンプー、リンス、トリートメント、ヘアト
ニック等の毛髪に適用されるものを挙げることができ
る。また、本発明の皮膚外用剤は、医薬用、医薬部外
用、化粧用のいずれにも用いることができる。
The external preparation for skin of the present invention means any dosage form that can be used externally, for example, lotion, emulsion, cream,
Foundations, packs, essences, lipsticks, facial cleansers, gels, aerosols, ointments, cataplasms, pastes, plasters, baths, cleaners, etc., and shampoos, rinses, treatments, hair tonics And the like applied to hair. Further, the external preparation for skin of the present invention can be used for any of medicine, quasi-drug, and cosmetic.

【0020】本発明の皮膚外用剤には、通常の皮膚外用
剤に用いられる成分である水性成分、油性成分、粉末成
分、ロウ類、脂肪酸類、アルコール類、エステル類、界
面活性剤、保湿剤、美白成分、紫外線吸収剤、増粘剤、
色剤、香料、抗酸化剤、pH調整剤、キレート剤、防腐
剤等を本発明の目的を達成する範囲内で適宜配合するこ
とができる。
The external preparation for skin of the present invention includes aqueous components, oil components, powder components, waxes, fatty acids, alcohols, esters, surfactants, humectants, which are components used in ordinary skin external preparations. , Whitening ingredients, UV absorbers, thickeners,
A coloring agent, a fragrance, an antioxidant, a pH adjuster, a chelating agent, a preservative, and the like can be appropriately compounded as long as the object of the present invention is achieved.

【0021】[0021]

【実施例】以下、実施例に基づいて本発明を詳細に説明
する。なお、本発明はこれらに限定されるものではな
い。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail based on embodiments. Note that the present invention is not limited to these.

【0022】[抽出例1](ブルセラ・ランシフォリア
(Bursera lancifolia)抽出物Iの製造) 乾燥したブルセラ・ランシフォリア(Bursera lancifol
ia)100gを1Lのメタノールで室温にて24時間抽
出、さらにその後2回同様に抽出を行った後、抽出液を
併せて濃縮乾固し、粉状固形物20.3gを得た。
[Extraction Example 1] (Production of Bursera lancifolia extract I) Dried Brusera lancifolia
ia) 100 g was extracted with 1 L of methanol at room temperature for 24 hours, and then extracted twice in the same manner. The extracts were combined and concentrated to dryness to obtain 20.3 g of a powdery solid.

【0023】[抽出例2](ブルセラ・ランシフォリア
(Bursera lancifolia)抽出物IIの製造) 乾燥したブルセラ・ランシフォリア(Bursera lancifol
ia)100gを水/エタノール(1:1、容量比)溶媒
1L中に入れ、室温で24時間攪拌しながら抽出を行っ
た後濾過し、その濾液を濃縮乾固し、粉状固形物15.
8gを得た。
[Extraction Example 2] (Production of Bursera lancifolia extract II) Dried Brusera lancifol
ia) 100 g was placed in 1 L of a water / ethanol (1: 1, volume ratio) solvent, extracted with stirring at room temperature for 24 hours, filtered, and the filtrate was concentrated to dryness to obtain a powdery solid.
8 g were obtained.

【0024】[抽出例3](ブルセラ・ランシフォリア
(Bursera lancifolia)抽出物IIIの製造) 乾燥したブルセラ・ランシフォリア(Bursera lancifol
ia)100gを1Lの1,3―ブチレングリコールと水
との混合液(1:1)で室温にて10日間抽出後濾過
し、その濾液を濃縮乾固し、粉状固形物17gを得た。
[Extraction Example 3] (Production of Bursera lancifolia extract III) Dried Brusera lancifolia
ia) 100 g was extracted with 1 L of a mixture of 1,3-butylene glycol and water (1: 1) at room temperature for 10 days, filtered, and the filtrate was concentrated to dryness to obtain 17 g of a powdery solid. .

【0025】[試験例1]上記抽出物の抗酸化能を調べ
るために、本発明において使用した評価試験法は以下の
通りである。尚、比較のために、既に抗酸化力を有する
ことで知られているローズマリー(学名:Rosmarinus o
fficinalis)の50%エタノール抽出物についても同様
の評価を行い、検体100ug/ml、10ug/ml
におけるラジカル除去率(%)を求めた。 (1) 活性酸素消去試験 80mM 炭酸ナトリウム緩衝液(pH10.2) に
3.8mU/ml キサンチンオキシダーゼ(XOD、
シグマ製)、0.2mM EDTA、100ug/ml
BSA(Bovine serum albumin、シグマ製)、50uM
NBT(ニトロブルーテトラゾリウム)となるように
溶解し、この混合物1.5mlに検体を0.03ml添
加し、30℃ 5分間プレインキュベートする。この液
に、0.2mM キサンチンナトリウム溶液 1.5ml
を添加し30℃ 20分間放置後、6mM塩化第二銅溶
液 0.1mlを加えて反応を停止させ、560nmで
吸光度(A)を測定する。XODの代わりに緩衝液を加
えたものの吸光度(B)、試験試料の代わりに緩衝液を
加えたものの吸光度(C)、試験試料とXODの代わり
に緩衝液を加えたものの吸光度(D)を測定し、下式に
従って阻害率を求めた。 活性酸素消去率(%)=(1−(A−B)/(C−
D))×100
Test Example 1 The evaluation test method used in the present invention to examine the antioxidant ability of the above extract is as follows. For comparison, rosemary (scientific name: Rosmarinus o.) Already known to have antioxidant power
fficinalis), the same evaluation was performed for a 50% ethanol extract, and 100 ug / ml and 10 ug / ml of the sample were obtained.
, The radical removal rate (%) was determined. (1) Active oxygen elimination test 3.8 mU / ml xanthine oxidase (XOD, 80 mM sodium carbonate buffer (pH 10.2))
Sigma), 0.2 mM EDTA, 100 ug / ml
BSA (Bovine serum albumin, Sigma), 50 uM
It is dissolved so as to become NBT (nitro blue tetrazolium), 0.03 ml of a sample is added to 1.5 ml of this mixture, and pre-incubation is performed at 30 ° C. for 5 minutes. 1.5 ml of 0.2 mM sodium xanthine solution
Is added and left at 30 ° C. for 20 minutes, the reaction is stopped by adding 0.1 ml of a 6 mM cupric chloride solution, and the absorbance (A) is measured at 560 nm. Measure the absorbance (B) of the buffer with the buffer added instead of XOD, the absorbance of the buffer with the buffer added instead of the test sample (C), and the absorbance of the buffer with the buffer added instead of the test sample and XOD (D). Then, the inhibition rate was determined according to the following equation. Active oxygen scavenging rate (%) = (1- (AB) / (C-
D)) × 100

【0026】(2) DPPHラジカル消去試験 中性ラジカルであるDiphenyl-p-picrylhydradil(DP
PH)のエタノール液を用いて、上記抽出物の脂質のラ
ジカル連鎖反応の阻止効果を検討した。250mM 酢
酸緩衝液(pH 5.5) 800ulにエタノール 8
00ul、検体20ulを混合し、30℃ 5分間プレ
インキュベートする。この液に、250uM DPPH
/エタノール溶液を400ul添加混合し30℃ 30
分間放置後、517nmの吸光度を測定し、その後30
0ug/ml BHT(3,5-tert-butyl-4-hydroxytole
n)20ulを添加し、完全にDPPHラジカルを除去
した場合の吸光度を測定する。この差から、ラジカル除
去率を求める。結果を第1表(表1)に示す。抽出例
1,2,3のブルセラ・ランシフォリア(Bursera lanc
ifolia)抽出物は、ローズマリー抽出物に匹敵するDP
PHラジカル消去作用及び活性酸素消去作用を有するこ
とがわかった。
(2) DPPH Radical Scavenging Test Diphenyl-p-picrylhydradil (DP
The inhibitory effect of the extract on the radical chain reaction of lipids was examined using an ethanol solution of PH). 250 mM acetate buffer (pH 5.5) Ethanol 8 in 800 ul
Mix 00 ul and 20 ul of the sample and pre-incubate at 30 ° C for 5 minutes. Add 250 uM DPPH to this solution
400 ul / ethanol solution, add 30 ℃ 30
After standing for 5 minutes, the absorbance at 517 nm was measured,
0 ug / ml BHT (3,5-tert-butyl-4-hydroxytole
n) Add 20 ul, and measure the absorbance when the DPPH radical is completely removed. From this difference, the radical removal rate is determined. The results are shown in Table 1 (Table 1). Bursera lancifolia (Bursera lanc)
ifolia) extract has a DP comparable to rosemary extract
It was found to have a PH radical scavenging action and an active oxygen scavenging action.

【0027】[0027]

【表1】 第1表 ──────────────────────────── 試験 DPPHラジカル除去率(%) 活性酸素消去率(%) 濃度(ug/ml) 100 10 100 10 ──────────────────────────── 抽出例1 98 100 70 70 抽出例2 100 100 73 70 抽出例3 100 95 80 75 ローズマリー抽出物 100 33 97 60 ────────────────────────────[Table 1] Table 1 Test DPPH radical removal rate (%) Active oxygen scavenging rate (%) Concentration (ug / ml) 100 10 100 10 例 Extraction example 1 98 100 70 70 Extraction example 2 100 100 73 70 Extraction example 3 100 95 80 75 Rosemary extract 100 33 97 60

【0028】[実施例1](クリーム) 下記記載の配合量においてB成分をA成分に混合し、均
一に加熱溶解して温度を80℃にした。次いでC成分を
注入撹拌混合した後、撹拌しながら30℃まで冷却しク
リームを得た。 (組成) 配合成分 配合量(wt%) (A) スクワラン 10.0 オリーブ油 10.0 固形パラフィン 5.0 セタノール 4.0 ソルビタンモノステアレート 2.0 ポリオキシエチレンソルビタンモノステアレート 2.0 (B) ブルセラ・ランシフォリア抽出物 抽出物I(抽出例1) 1.0 (C) グリセリン 5.0 メチルパラペン 0.1 精製水 100wt%残量
[Example 1] (Cream) The B component was mixed with the A component in the following amount, and the mixture was uniformly heated and dissolved to a temperature of 80 ° C. Next, the C component was poured and mixed, and then cooled to 30 ° C. while stirring to obtain a cream. (Composition) Blended ingredients Blended amount (wt%) (A) Squalane 10.0 Olive oil 10.0 Solid paraffin 5.0 Cetanol 4.0 Sorbitan monostearate 2.0 Polyoxyethylene sorbitan monostearate 2.0 (B) Brucella ransifolia extract Extract I (Extraction example) 1) 1.0 (C) Glycerin 5.0 Methyl parapen 0.1 Purified water 100wt% remaining

【0029】[比較例1](クリーム) 実施例1において成分(B)ブルセラ・ランシフォリア
(Bursera lancifolia)抽出物を除いた以外はすべて実
施例1と同様にして調製し、前述した各試験に使用し
た。
[Comparative Example 1] (Cream) Except for removing the component (B) Brusera lancifolia extract in Example 1, all were prepared in the same manner as in Example 1 and used in the above-described tests. did.

【0030】[実施例2](二相型ローション) 下記記載の配合量においてA成分を室温にて均一に混合
溶解し、B成分をゆっくり撹拌添加し二相型ローション
を得た。 (組成) 配合成分 配合量(wt%) (A) オリーブ油 15.0 ミリスチン酸イソプロピル 5.0 ポリオキシエチレンノニル フェノールエーテル(2E.O.) 0.5 グリセリン 5.0 メチルパラペン 0.1 エタノール 7.0 精製水 65.4 (B) 抽出物III(抽出例3) 2.0
Example 2 (Two-Phase Lotion) The A component was uniformly mixed and dissolved at room temperature in the following amount, and the B component was slowly added by stirring to obtain a two-phase lotion. (Composition) Ingredients Ingredients Amount (wt%) (A) Olive oil 15.0 Isopropyl myristate 5.0 Polyoxyethylene nonyl phenol ether (2E.O.) 0.5 Glycerin 5.0 Methyl parapen 0.1 Ethanol 7.0 Purified water 65.4 (B) Extract III (extraction) Example 3) 2.0

【0031】[比較例2](二相型ローション) 実施例2において成分(B)ブルセラ・ランシフォリア
(Bursera lancifolia)抽出物を除いた以外はすべて実
施例2と同様にして調製し、前述した各試験に使用し
た。
[Comparative Example 2] (Biphasic lotion) Except for removing the component (B) Bursera lancifolia extract in Example 2, all preparations were carried out in the same manner as in Example 2, and Used for testing.

【0032】[試験例2]有用性評価試験 健康な女性(25〜40才)80名を20名ずつに4群
に分け、それぞれ実施例1、2及び比較例1,2の試料
を1日2回ずつ塗布し、塗布開始後3ヶ月後の老化防止
効果(肌荒れ防止、皮膚の艶・張り)についてアンケー
ト調査を行って評価した。アンケートの評価基準は、有
効なものを「優」、やや有効なものを「良」、わずかに
有効なものを「可」、無効なものを「不可」として、比
較例と比較して評価を行った。第2表(表2)に示すご
とく、比較例1、2に比べ実施例1、2では良好な結果
が得られた。
[Test Example 2] Usefulness evaluation test Eighty healthy women (25 to 40 years old) were divided into four groups of 20 persons each, and the samples of Examples 1 and 2 and Comparative Examples 1 and 2 were taken for 1 day. It was applied twice, and a questionnaire survey was conducted to evaluate the anti-aging effect (prevention of rough skin, gloss / tension of skin) three months after the start of application. The evaluation criteria of the questionnaire were evaluated as "excellent" for valid items, "good" for slightly effective items, "acceptable" for slightly effective items, and "impossible" for invalid items. went. As shown in Table 2 (Table 2), better results were obtained in Examples 1 and 2 than in Comparative Examples 1 and 2.

【0033】[0033]

【表2】 第2表 ─────────────────────────────── 試験 肌荒れ防止効果 皮膚の艶・張り促進効果 効果 優 良 可 不可 優 良 可 不可 ─────────────────────────────── 実施例1 15 4 1 0 19 1 0 0 比較例1 0 0 0 20 0 1 1 18 実施例2 18 2 0 0 18 2 0 0 比較例2 0 1 0 19 0 0 3 17 ─────────────────────────────── 注)数値は人数[Table 2] Table 2 ─────────────────────────────── Test Skin roughening prevention effect Skin gloss / tension promoting effect Excellent OK Not possible Excellent OK Not possible ─────────────────────────────── Example 1 15 4 10 19 19 0 0 Comparative Example 1 0 0 0 20 0 1 1 18 Example 2 18 2 0 0 18 2 0 0 Comparative Example 2 0 1 0 1 0 0 0 3 17 ────────────── Note) Number is the number of people

【0034】[実施例3](油性軟膏) 下記記載の配合量において各成分を混合し、80℃まで
加温し徐々に冷却し油性軟膏を得た。 (組成) 配合成分 配合量(wt%) (A)ワセリン 96.0 ショートニングオイル 3.0 (B)抽出物I(抽出例1) 1.0
Example 3 (Ointment) An oily ointment was obtained by mixing the components in the following amounts, heating to 80 ° C., and gradually cooling. (Composition) Blended components Blended amount (wt%) (A) Vaseline 96.0 Shortening oil 3.0 (B) Extract I (Extraction Example 1) 1.0

【0035】[試験例3]実施例3において調製された
油性軟膏を試験例1の抗酸化効果の評価試験法に示す方
法と同様の方法に準じ抗酸化試験を行った。その結果、
該油性軟膏は(B)成分を配合しない以外は、全ての成
分を含む油性軟膏と比べて、DPPHラジカル消去作用
及び活性酸素消去作用に優れていた。
Test Example 3 The oil-based ointment prepared in Example 3 was subjected to an antioxidant test according to the same method as the test method shown in Test Example 1 for evaluating the antioxidant effect. as a result,
The oil-based ointment was excellent in the DPPH radical scavenging action and the active oxygen scavenging action as compared to the oil-based ointment containing all components except that the component (B) was not blended.

【0036】[0036]

【発明の効果】以上記載の如く、本発明の抗酸化剤を含
む化粧品、医薬品、医薬部外品、食品等の組成物は、生
体内に生成した活性酸素や過酸化脂質によって引き起こ
される障害を抑制する効果がある。従って、健康上、美
容上の障害についての治療に有効であり、さらに飲食品
の安定化・保存性の向上にも有用である。
As described above, compositions such as cosmetics, pharmaceuticals, quasi-drugs, and foods containing the antioxidant of the present invention can be used to prevent disorders caused by active oxygen and lipid peroxide generated in vivo. It has the effect of suppressing. Therefore, it is effective for treating health and cosmetic disorders, and is also useful for stabilizing and improving the preservability of food and drink.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 原口 博行 広島県福山市清水ケ丘11−3 Fターム(参考) 4C083 AA111 AA112 AA122 AC012 AC022 AC072 AC102 AC122 AC182 AC352 AC442 AC482 BB47 BB51 CC02 CC05 DD05 DD22 DD28 DD31 EE10 EE12 FF01 FF05 4C088 AB12 AB99 AC03 AC04 AC05 AC06 AC11 AC13 BA08 BA09 BA10 MA63 NA14 ZA33 ZA36 ZA42 ZA45 ZA75 ZA89 ZC21 ZC37  ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Hiroyuki Haraguchi 11-3 F-term (reference) 11-3 Shimizugaoka, Fukuyama-shi, Hiroshima 4C083 AA111 AA112 AA122 AC012 AC022 AC072 AC102 AC122 AC182 AC352 AC442 AC482 BB47 BB51 CC02 CC05 DD05 DD22 DD28 DD31 EE10 EE12 FF01 FF05 4C088 AB12 AB99 AC03 AC04 AC05 AC06 AC11 AC13 BA08 BA09 BA10 MA63 NA14 ZA33 ZA36 ZA42 ZA45 ZA75 ZA89 ZC21 ZC37

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 ブルセラ・ランシフォリア(Bursera la
ncifolia)の抽出物を含有することを特徴とする抗酸化
剤。
[Claim 1] Bursera lancifolia
An antioxidant comprising an extract of ncifolia).
【請求項2】 請求項1に記載の抗酸化剤を含有するこ
とを特徴とする組成物。
2. A composition comprising the antioxidant according to claim 1.
【請求項3】 請求項1に記載の抗酸化剤を含有するこ
とを特徴とする皮膚外用剤。
3. An external preparation for skin, comprising the antioxidant according to claim 1.
JP251099A 1999-01-08 1999-01-08 Antioxidant and composition containing the same Expired - Fee Related JP3597068B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP251099A JP3597068B2 (en) 1999-01-08 1999-01-08 Antioxidant and composition containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP251099A JP3597068B2 (en) 1999-01-08 1999-01-08 Antioxidant and composition containing the same

Publications (2)

Publication Number Publication Date
JP2000198714A true JP2000198714A (en) 2000-07-18
JP3597068B2 JP3597068B2 (en) 2004-12-02

Family

ID=11531380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP251099A Expired - Fee Related JP3597068B2 (en) 1999-01-08 1999-01-08 Antioxidant and composition containing the same

Country Status (1)

Country Link
JP (1) JP3597068B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002053478A (en) * 2000-08-10 2002-02-19 Maruzen Pharmaceut Co Ltd Skin care preparation
US20140335043A1 (en) * 2013-05-10 2014-11-13 Johnson & Johnson Consumer Companies, Inc. Compositions comprising extracts of bursera simaruba

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002053478A (en) * 2000-08-10 2002-02-19 Maruzen Pharmaceut Co Ltd Skin care preparation
JP4707214B2 (en) * 2000-08-10 2011-06-22 丸善製薬株式会社 Skin preparation
US20140335043A1 (en) * 2013-05-10 2014-11-13 Johnson & Johnson Consumer Companies, Inc. Compositions comprising extracts of bursera simaruba
US9579278B2 (en) 2013-05-10 2017-02-28 Johnson & Johnson Consumer Inc. Compositions comprising extracts of Bursera simaruba
US10406096B2 (en) 2013-05-10 2019-09-10 Johnson & Johnson Consumer Inc. Compositions comprising extracts of Bursera simaruba

Also Published As

Publication number Publication date
JP3597068B2 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
KR20230117253A (en) Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
JP3135943B2 (en) Whitening agent
JPH09263534A (en) Promoter for melanogenesis
JP2004115466A (en) Skin care preparation for external use
JP2810107B2 (en) Cosmetic composition for skin
JPH09118611A (en) Cosmetic
JP2002121112A (en) Skin care preparation
JP2002249772A (en) Antioxidant and composition including the same
KR20190137329A (en) Skin external application composition for anti-aging containing Phlox subulata extract
KR20190137327A (en) Skin external application composition for anti-aging
JP3647295B2 (en) Lipid peroxide production inhibitor and composition containing the same
JP3597068B2 (en) Antioxidant and composition containing the same
JP3226359B2 (en) Lipid peroxide production inhibitor and composition containing the same
JP3628196B2 (en) Antioxidant and composition containing the same
JP2000198980A (en) Antioxidant and composition containing same
JP3792053B2 (en) Lipid peroxide production inhibitor and composition containing the same
JP2000198740A (en) Inhibitor of lipid peroxide production and composition containing the same
JP2003238425A (en) Thyrosinase inhibitor and skin external agent
JP3647296B2 (en) Inhibition of tyrosinase activity and compositions containing the same
JP3597067B2 (en) Antioxidant and composition containing the same
JP2000198715A (en) Lipid peroxide formation inhibitor and composition containing the same
JP3224962B2 (en) External preparation for skin
KR20190137328A (en) Skin external application composition for anti-aging containing Rhodotypos scandens extract
JPH1046142A (en) Antioxidant
JPH0751510B2 (en) Anti-active oxygen agent and anti-active oxygen agent containing the same as an active ingredient, food, cosmetics and pharmaceuticals

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040825

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040907

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040907

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees